Decision Diagnostics Stock Technical Analysis
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Decision Diagnostics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Decision, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DecisionDecision |
Decision Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Decision Diagnostics Technical Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Decision Diagnostics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Decision Diagnostics Trend Analysis
Use this graph to draw trend lines for Decision Diagnostics. You can use it to identify possible trend reversals for Decision Diagnostics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Decision Diagnostics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Decision Diagnostics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Decision Diagnostics applied against its price change over selected period. The best fit line has a slop of 0.00 , . It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Decision Diagnostics price change compared to its average price change.About Decision Diagnostics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Decision Diagnostics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Decision Diagnostics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Decision Diagnostics price pattern first instead of the macroeconomic environment surrounding Decision Diagnostics. By analyzing Decision Diagnostics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Decision Diagnostics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Decision Diagnostics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2019 | 2020 | 2023 | 2024 (projected) | PTB Ratio | 24.89 | 9.92 | 8.93 | 9.38 | Price To Sales Ratio | 0.92 | 2.42 | 2.79 | 2.65 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.